Skip to main content
. 2024 Jul 25;7(7):e2423933. doi: 10.1001/jamanetworkopen.2024.23933

Table 4. Association of Neonatal Morbidities With Treatment-Warranted ROP in the Norwegian Neonatal Network.

Variablea Univariable analysis, OR (95% CI) P value Multivariable analysis, aOR (95% CI) P value
Neonatal sepsis 2.16 (1.48-3.14) <.001 0.97 (0.64-1.47) .88
Sepsis episodes, No.b
1 1.61 (1.04-2.50) .03 0.77 (0.47-1.23) .29
2 5.30 (2.72-10.34) <.001 1.96 (0.94-4.10) .07
3 6.29 (1.60-24.73) .008 1.89 (0.40-8.83) .42
NEC requiring surgery 7.30 (4.12-12.95) <.001 3.37 (1.78-6.37) <.001
SGA 1.47 (1.01-2.15) .05 1.53 (1.01-2.32) .04
GA, wkc 0.54 (0.48-0.60) <.001 0.63 (0.54-0.72) <.001
Severe BPD 3.84 (2.69-5.46) <.001 1.80 (1.21-2.67) .004
Apgar score at 5 min <7 0.58 (0.41-0.82) .002 1.02 (0.71-1.52) .83

Abbreviations: aOR, adjusted odds ratio; BPD, bronchopulmonary dysplasia; GA, gestational age; NEC, necrotizing enterocolitis; OR, odds ratio; ROP, retinopathy of prematurity; SGA, small for gestational age.

a

Variables not associated with treatment-warranted ROP in univariable analysis were female sex, intraventricular hemorrhage grade 3 to 4, and cystic periventricular leukomalacia.

b

The reference group was infants with 0 sepsis episodes.

c

Outcomes were per 1-week increase in GA.